sarclisa.com
#8,068,663
Global Rankeez rank — last updated 01 Sep 2026
Better than 92.0% of the 100,511,422 domains we track
Best rank recorded
#8,068,663
2026-09
Worst rank recorded
#21,260,010
2026-07
Tracked since
2026-07
5 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how sarclisa.com scores in each:
| Source | Rank |
|---|---|
| DomCop / OpenPageRank | #7,250,712 |
| CommonCrawl (hyperlink graph) | #5,964,358 |
See how these sources are combined and cross-validated →
Ranking history
sarclisa.com's rank across 5 monthly snapshots. ▲ improved by 13,191,347 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #21,260,010 |
| 2026-08 | #21,252,692 |
| 2026-09 | #8,068,663 |
| 2026-10 | #8,070,454 |
| 2026-11 | #8,068,663 |
JSON API
{
"sarclisa.com": 8068663,
"history": {
"2026-07": 21260010,
"2026-08": 21252692,
"2026-09": 8068663,
"2026-10": 8070454,
"2026-11": 8068663
}
}
GET https://rankeez.com/api/sarclisa.com.json · see API docs →
More about sarclisa.com
sarclisa.com — page content & similar sites →
SARCLISA is a targeted monoclonal antibody for adults with multiple myeloma who have received at least 2 prior therapies. See Important Safety & full Prescribing Info.
sarclisa.com — full site profile →
WHOIS, tech stack and extended traffic history for sarclisa.com.